We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Applied Graphene Materials Plc | LSE:AGM | London | Ordinary Share | GB00BFSSB742 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.25 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAGM
RNS Number : 3870W
Applied Graphene Materials PLC
01 August 2018
Applied Graphene Materials plc
("Applied Graphene Materials", "AGM", "the Group" or "the Company")
Board Change
Further to the announcement on 29 June 2018, Dr. Adrian Potts has commenced his role as Chief Executive Officer of the Company with effect from today, 1 August 2018. Accordingly, Jon Mabbitt has stepped down from the Board and, as previously announced, will continue in a part time advisory role to support the further development of the Company.
Dr. Bryan Dobson, Non-Executive Chairman of AGM, commented:
"I would like to welcome Adrian to the Board of AGM and look forward to working with him in the next phase of AGM's evolution.
I would also like to take this opportunity to thank Jon for his major contribution to the development of AGM. As CEO he has led the Company from a start-up to an established organisation set to play a key role in the use of graphene in major industrial applications."
Regulatory disclosures
In accordance with Schedule 2(g) of the AIM Rules, Dr. Hugh Adrian Potts (aged 57) holds or has held the following directorships and partnerships:
Current Past five years None Cytec Process Materials Inc
Adrian Potts holds 18,109 ordinary shares in the Company.
Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.
+44 (0) 1642 438 Applied Graphene Materials 214 Bryan Dobson, Chairman Adrian Potts, Chief Executive Officer Gareth Jones, Chief Financial Officer +44 (0) 207 496 N+1 Singer 3000 Richard Lindley / James White +44 (0) 207 796 Hudson Sandler 4133 Charlie Jack / Emily Dillon
Notes to Editors
Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University. The Group is based at the Wilton Site on Teesside and was admitted to AIM in November 2013, initially raising GBP11 million.
The Group has developed proprietary bottom-up processes which are capable of producing high purity graphene nanoplatelets using a continuous process. The manufacturing processes are based on sustainable, readily available raw materials and therefore do not rely on the supply of graphite, unlike a number of other graphene production techniques. Applied Graphene Materials owns the intellectual property and know-how behind these processes.
Applied Graphene Materials works in partnership with its customers using its knowledge and expertise to provide bespoke graphene dispersions and formats to deliver enhancements and benefits for a wide range of applications.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOAWGUMCMUPRGQG
(END) Dow Jones Newswires
August 01, 2018 02:01 ET (06:01 GMT)
1 Year Applied Graphene Materials Chart |
1 Month Applied Graphene Materials Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions